TCIM
CTSO icon

TIAA CREF Investment Management’s Cytosorbents Corp CTSO Stock Holding History

TIAA CREF Investment Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$421K Sell
55,672
-485
-0.9% -$3.78K ﹤0.01% 2662
2018
Q4 		$454K Sell
56,157
-675
-1% -$6.7K ﹤0.01% 2610
2018
Q3 		$733K Sell
56,832
-6,232
-10% -$78.1K ﹤0.01% 2561
2018
Q2 		$719K Buy
+63,064
New +$597K ﹤0.01% 2630

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

TIAA CREF Investment Management's CTSO Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Cytosorbents Corp (CTSO) stake by 0.86% in Q1 2019, selling an estimated $3.78K and leaving 55,672 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #2662.

TIAA CREF Investment Management first reported a position in CTSO in Q2 2018 and has held it in 4 quarters since. The position peaked at $733K in Q3 2018. 77 funds tracked by Wall St. Rank hold CTSO as of Q1 2019.

  • TIAA CREF Investment Management held 55,672 shares of Cytosorbents Corp worth $421K as of Q1 2019.
  • TIAA CREF Investment Management sold 485 Cytosorbents Corp shares in Q1 2019, an estimated $3.78K.
  • Cytosorbents Corp made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2662 holding.
  • TIAA CREF Investment Management first reported a position in Cytosorbents Corp in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's Cytosorbents Corp position peaked at $733K in Q3 2018.
  • 77 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.